В данной статье представлен обзор патогенетических механизмов, характерных для воспалительной реакции при старении и остеоартрите, а также точки приложения фармакологического действия компонентов препарата Алфлутоп.

1.    Кишкун А.А. Биологический возраст и старение: возможности определения и пути коррекции. Руководство для врачей. М.: ГЭОТАР-Медиа, 2008.
[Kishkun A.A. Biological age and aging: the possibilities of determining and ways of correction. Rukovodstvo dlia vrachei. Moscow: GEOTAR-Media, 2008 (in Russian).]
2.    Гериатрия. Национальное руководство. Под ред. О.Н.Ткачевой, Е.В.Фроловой, Н.Н.Яхно. Сер.: Национальные руководства. М.: ГЭОТАР-Медиа, 2018.
[Geriatrics. National leadership. Pod red. O.N.Tkachevoi, E.V.Frolovoi, N.N.Iakhno. Ser.: Natsional'nye rukovodstva. Moscow: GEOTAR-Media, 2018 (in Russian).]
3.    Franceschi C, Garagnani P, Parini P et al. Inflammaging: a new immune–metabolic viewpoint for age-related diseases. Nat Rev Endocrinol 2018; 14 (10): 576–90.
4.    Shijin Xia, Xinyan Zhang, Songbai Zheng et al. An Update on Inflamm-Aging: Mechanisms, Prevention, and Treatment. J Immunol Res 2016; 2016: 8426874.
5.    Minamino T, Yoshida T, Tatenoetal K. Ras induces vascular smooth muscle cell senescence and in ammation in human atherosclerosis. Circulation 2003; 108 (18): 2264–9.
6.    Quillard T, Charreau B. Impact of Notch signaling on in ammatory responses in cardiovascular disorders. Int J Mol Sci 2013; 14 (4): 6863–88.
7.    Ebersole JL et al. Aging, inflammation, immunity and periodontal disease. Periodontol 2000. 2016; 72: 54–75.
8.    Franceschi C, Garagnani P, Vitale G et al. Inflammaging and "garb-aging". Trends Endocrinol Metab 2017; 28: 199–212.
9.    Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med 2014; 69: S4–S9.
10.    Puts MTE, Toubasi S, Andrew MK et al. Interventions to prevent or reduce the level of frailty in community-dwelling older adults: a scoping review of the literature and international policie. Age Ageing 2017; 46: 383–92.
11.    Rydwik E, Frändin K, Akner G. Effects of a physical training and nutritional intervention program in frail elderly people regarding habitual physical activity level and activities of daily living. A randomized controlled pilot study. Arch Gerontol Geriatr 2010; 51: 283–9.
12.    Государственный реестр лекарственных средств. Available at: grls.rosminzdrav.ru
[Gosudarstvennyi reestr lekarstvennykh sredstv. Available at: grls.rosminzdrav.ru (in Russian).]
13.    Glyn-Jones S, Palmer AJ, Agricola R et al. Osteoarthritis. Lancet 2015; 386 (9991): 376–87.
14.    GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388 (10053): 1545–602.1
15.    March L, Smith EU, Hoy DG et al. Burden of disability due to musculoskeletal (MSK) disorders. Best Pract Res Clin Rheumatol 2014; 28 (3): 353–66.
16.    Jerosch J. E Effects of Glucosamine and Chondroitin Sulfate on Cartilage Metabolism in OA: Outlook on Other Nutrient Partners Especially Omega-3 Fatty Acids. Int J Rheumatol 2011; 2011: 969012.
17.    Yamazaki K, Fukuda K, Matsukawa M et al. Cyclic tensile stretch loaded on bovine chondrocytes causes depolymerization of hyaluronan: involvement of reactive oxygen species. Arthritis Rheum 2003; 48: 3151–8.
18.    Kurz B, Lemke A, Kehn M et al. Influence of tissue maturation and antioxidants on the apoptotic response of articular cartilage after injurious compression. Arthritis Rheum 2004; 50: 123–30.
19.    Bar-Or D, Rael LT, Thomas GW, Brody EN. Inflammatory Pathways in Knee Osteoarthritis: Potential Targets for Treatment. Curr Rheumatol Rev 2015; 11 (1): 50–8.
20.    Sokolove J, Lepus CM. Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations. Ther Adv Musculoskelet Dis 2013; 5 (2): 77–94.
21.    Панасюк А.Ф., Ларионов Е.В. Хондроитинсульфаты и их роль в обмене хондроцитов и межклеточного матрикса хрящевой ткани. Научно-практическая ревматология. 2000;
2: 46–55.
[Panasiuk A.F., Larionov E.V. Khondroitinsul'faty i ikh rol' v obmene khondrotsitov i mezhkletochnogo matriksa khriashchevoi tkani. Nauchno-prakticheskaia revmatologiia. 2000; 2: 46–55
(in Russian).]
22.    Stabler TV, Huang Z, Montell E et al. Chondroitin sulphate inhibits NF-kB activity induced by interaction of pathogenic and damage associated molecules. Osteoarthritis Cartilage 2017; 25: 166–74.
23.    Бадокин В.В. Клиническая оценка фармакологической активности препарата хондроитина сульфат. Лечащий врач. 2012; 10: 92.
[Badokin V.V. Klinicheskaia otsenka farmakologicheskoi aktivnosti preparata khondroitina sul'fat. Lechashchii vrach. 2012; 10: 92 (in Russian).]
24.    Mocchegiani E, Costarelli L, Giacconi R et al. Nutrient-gene interaction in ageing and successful ageing. A single nutrient (zinc) and some target genes related to inflammatory/immune response. Mechanisms Ageing Development 2006; 127 (6): 517–25.
25.    Claxon A, Morris C, Blake D et al. The anti-inflammatorv efectsof D-myo-inositol-1.2.6-trisphosphate (PP56) on animal models of inflammation. Agents Actions 1990; 29: 68–70.
26.    Kidd BL, Cruwys S, Mapp PI, Blake DR. Role of thesympathetic nervous system in chronic joint pain and inflammation. Ann RheumaticDis 1992; 51: 1188–91.
27.    Ostrin EJ et al. Myo-Inositol Reduces Pro-Tumoral IL6 Inflammation in a Mouse Model of Lung Cancer Chemoprevention. Am J Respir Crit Care Med 2017; 195: A4955.
28.    Saxena RN, Pendse VK, Khanna NK. Anti-inflammatory and analgesic properties of four amino-acids. Ind J Physiol Pharmacol 1984; 28 (4): 299–305.
29.    Олариу Л., Димитриу Б., Бусэ Э., Росоиу Н. In vitro эффект препарата алфлутоп на некоторые внеклеточные сигнальные факторы, участвующие в воспалении при остеоартрите. Вестн. Академии румынских ученых. Статьи по биологическим наукам. 2015; 4 (2).
[Olariu L., Dimitriu B., Buse E., Rosoiu N. In vitro effekt preparata alflutop na nekotorye vnekletochnye signal'nye faktory, uchastvuiushchie v vospalenii pri osteoartrite. Vestn. Akademii rumynskikh uchenykh. Stat'i po biologicheskim naukam. 2015; 4 (2) (in Russian).]
30.    Олариу Л., Пятигорская Н., Димитриу Б. и др. In vitro хондровосстановительная способность препарата алфлутоп, доказанная на культурах хондроцитов. Roman Biotech Letters 2016; 22 (6).
31.    Ndeh D, Munoz Munoz J, Cartmell A et al. The human gut microbe Bacteroides thetaiotaomicron encodes the founding member of a novel glycosaminoglycan-degrading polysaccharide lyase family PL29. JBC 2018; 293 (46): 17906–16.
[Olariu L., Piatigorskaia N., Dimitriu B. et al. In vitro khondrovosstanovitel'naia sposobnost' preparata alflutop, dokazannaia na kul'turakh khondrotsitov. Roman Biotech Letters 2016; 22 (6) (in Russian).]
32.    Алексеева Л.И., Таскина Е.А., Лила А.М. и др. Многоцентровое проспективное рандомизированное исследование эффективности и безопасности препарата Алфлутоп® в альтернирующем режиме по сравнению со стандартным режимом. Сообщение 1: оценка эффективности препарата при различных схемах применения. Современная ревматология. 2019. 13 (3): 51–9.
[Alekseeva L.I., Taskina E.A., Lila A.M. et al. Mnogotsentrovoe prospektivnoe randomizirovannoe issledovanie effektivnosti i bezopasnosti preparata Alflutop® v al'terniruiushchem rezhime po sravneniiu so standartnym rezhimom. Soobshchenie 1: otsenka effektivnosti preparata pri razlichnykh skhemakh primeneniia. Sovremennaia revmatologiia. 2019. 13 (3): 51–9 (in Russian).]